{"id":108028,"date":"2026-06-03T00:18:50","date_gmt":"2026-06-02T22:18:50","guid":{"rendered":"https:\/\/www.infokuryr.cz\/n\/?p=108028"},"modified":"2026-06-02T13:07:37","modified_gmt":"2026-06-02T11:07:37","slug":"nejvetsi-studie-o-lecbe-rakoviny-u-lidi-s-kombinaci-ivermektinu-a-mebendazolu-byla-nyni-recenzovana-a-publikovana-v-renomovanem-onkologickem-casopise","status":"publish","type":"post","link":"https:\/\/www.infokuryr.cz\/n\/2026\/06\/03\/nejvetsi-studie-o-lecbe-rakoviny-u-lidi-s-kombinaci-ivermektinu-a-mebendazolu-byla-nyni-recenzovana-a-publikovana-v-renomovanem-onkologickem-casopise\/","title":{"rendered":"Nejv\u011bt\u0161\u00ed studie o l\u00e9\u010db\u011b rakoviny u lid\u00ed s kombinac\u00ed ivermektinu a mebendazolu byla nyn\u00ed recenzov\u00e1na a publikov\u00e1na v renomovan\u00e9m onkologick\u00e9m \u010dasopise"},"content":{"rendered":"<div id=\"fb-root\"><\/div>\n<div class=\"elementor-element elementor-element-1fb4c2c elementor-widget elementor-widget-theme-post-content\" data-id=\"1fb4c2c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"theme-post-content.default\">\n<div class=\"elementor-widget-container\">\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong><span dir=\"auto\">84,4 % pacient\u016f s rakovinou, kte\u0159\u00ed u\u017e\u00edvali ivermektin + mebendazol po dobu 6 m\u011bs\u00edc\u016f, hl\u00e1silo bu\u010f ZMIZEN\u00cd RAKOVINY, REGRESI N\u00c1DORU, nebo STABILIZACI RAKOVINY.<\/span><\/strong><\/p>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">Dosud nejv\u011bt\u0161\u00ed re\u00e1ln\u00e1 studie na lidech hodnot\u00edc\u00ed ivermektin a mebendazol u pacient\u016f s rakovinou byla\u00a0<\/span><strong><a href=\"https:\/\/ar.iiarjournals.org\/content\/46\/6\/3243\" target=\"_blank\" rel=\"noreferrer noopener\" data-type=\"link\" data-id=\"https:\/\/ar.iiarjournals.org\/content\/46\/6\/3243\"><span dir=\"auto\">recenzov\u00e1na a<\/span><\/a><\/strong>\u00a0<a href=\"https:\/\/ar.iiarjournals.org\/content\/46\/6\/3243\" target=\"_blank\" rel=\"noreferrer noopener\" data-type=\"link\" data-id=\"https:\/\/ar.iiarjournals.org\/content\/46\/6\/3243\"><span dir=\"auto\">publikov\u00e1na\u00a0<\/span><\/a><span dir=\"auto\"><strong>v\u00a0<\/strong><strong><em><a href=\"https:\/\/ar.iiarjournals.org\/content\/46\/6\/3243\" target=\"_blank\" rel=\"noreferrer noopener\" data-type=\"link\" data-id=\"https:\/\/ar.iiarjournals.org\/content\/46\/6\/3243\">\u010dasopise Anticancer Research<\/a><\/em><\/strong>\u00a0\u2013 p\u0159edn\u00edm mezin\u00e1rodn\u00edm onkologick\u00e9m \u010dasopise Mezin\u00e1rodn\u00edho institutu pro v\u00fdzkum rakoviny (IIAR), zalo\u017een\u00e9ho v roce 1995.<\/span><\/p>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">Na\u0161e studie s n\u00e1zvem\u00a0<\/span><strong><span dir=\"auto\">\u201e\u00a0<\/span><a href=\"https:\/\/ar.iiarjournals.org\/content\/46\/6\/3243\" target=\"_blank\" rel=\"noreferrer noopener\"><span dir=\"auto\">Klinick\u00e9 v\u00fdsledky u\u017e\u00edv\u00e1n\u00ed ivermektinu a mebendazolu u pacient\u016f s rakovinou v re\u00e1ln\u00e9m sv\u011bt\u011b: V\u00fdsledky prospektivn\u00ed observa\u010dn\u00ed kohorty<\/span><\/a><span dir=\"auto\">\u00a0\u201c<\/span><\/strong><span dir=\"auto\">\u00a0p\u0159edstavuje jeden z nejp\u0159esv\u011bd\u010div\u011bj\u0161\u00edch klinick\u00fdch sign\u00e1l\u016f, kter\u00e9 kdy byly zdokumentov\u00e1ny pro op\u011btovn\u00e9 vyu\u017eit\u00ed antiparazit\u00e1rn\u00edch terapi\u00ed v onkologii.<\/span><\/p>\n<div class=\"twitter-tweet twitter-tweet-rendered\"><iframe id=\"twitter-widget-0\" class=\"\" title=\"X Post\" src=\"https:\/\/platform.twitter.com\/embed\/Tweet.html?dnt=false&amp;embedId=twitter-widget-0&amp;features=eyJ0ZndfdGltZWxpbmVfbGlzdCI6eyJidWNrZXQiOltdLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X2ZvbGxvd2VyX2NvdW50X3N1bnNldCI6eyJidWNrZXQiOnRydWUsInZlcnNpb24iOm51bGx9LCJ0ZndfdHdlZXRfZWRpdF9iYWNrZW5kIjp7ImJ1Y2tldCI6Im9uIiwidmVyc2lvbiI6bnVsbH0sInRmd19yZWZzcmNfc2Vzc2lvbiI6eyJidWNrZXQiOiJvbiIsInZlcnNpb24iOm51bGx9LCJ0ZndfZm9zbnJfc29mdF9pbnRlcnZlbnRpb25zX2VuYWJsZWQiOnsiYnVja2V0Ijoib24iLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X21peGVkX21lZGlhXzE1ODk3Ijp7ImJ1Y2tldCI6InRyZWF0bWVudCIsInZlcnNpb24iOm51bGx9LCJ0ZndfZXhwZXJpbWVudHNfY29va2llX2V4cGlyYXRpb24iOnsiYnVja2V0IjoxMjA5NjAwLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X3Nob3dfYmlyZHdhdGNoX3Bpdm90c19lbmFibGVkIjp7ImJ1Y2tldCI6Im9uIiwidmVyc2lvbiI6bnVsbH0sInRmd19kdXBsaWNhdGVfc2NyaWJlc190b19zZXR0aW5ncyI6eyJidWNrZXQiOiJvbiIsInZlcnNpb24iOm51bGx9LCJ0ZndfdXNlX3Byb2ZpbGVfaW1hZ2Vfc2hhcGVfZW5hYmxlZCI6eyJidWNrZXQiOiJvbiIsInZlcnNpb24iOm51bGx9LCJ0ZndfdmlkZW9faGxzX2R5bmFtaWNfbWFuaWZlc3RzXzE1MDgyIjp7ImJ1Y2tldCI6InRydWVfYml0cmF0ZSIsInZlcnNpb24iOm51bGx9LCJ0ZndfbGVnYWN5X3RpbWVsaW5lX3N1bnNldCI6eyJidWNrZXQiOnRydWUsInZlcnNpb24iOm51bGx9LCJ0ZndfdHdlZXRfZWRpdF9mcm9udGVuZCI6eyJidWNrZXQiOiJvbiIsInZlcnNpb24iOm51bGx9fQ%3D%3D&amp;frame=false&amp;hideCard=false&amp;hideThread=false&amp;id=2061448556477812741&amp;lang=cs&amp;origin=https%3A%2F%2Funcutnews.ch%2Fdie-groesste-krebsstudie-am-menschen-zu-ivermectin-mebendazol-wurde-nun-von-fachkollegen-begutachtet-und-in-einer-renommierten-krebsfachzeitschrift-veroeffentlicht%2F&amp;sessionId=2c79ebce414165758f4d6a846540dfdc2e9a6fe6&amp;theme=light&amp;widgetsVersion=6a3ad42b224df%3A1778106238597&amp;width=550px\" frameborder=\"0\" scrolling=\"no\" allowfullscreen=\"allowfullscreen\" data-tweet-id=\"2061448556477812741\" data-mce-fragment=\"1\"><\/iframe><\/div>\n<figure class=\"wp-block-image aligncenter size-large\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter\" title=\"Nejv\u011bt\u0161\u00ed studie o l\u00e9\u010db\u011b rakoviny u lid\u00ed s kombinac\u00ed ivermektinu a mebendazolu byla nyn\u00ed recenzov\u00e1na a publikov\u00e1na v renomovan\u00e9m onkologick\u00e9m \u010dasopise.\" src=\"https:\/\/substackcdn.com\/image\/fetch\/$s_!O8zp!,w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep\/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F6199335b-190e-4997-8b05-17006351e80b_2237x2231.png\" alt=\"Nejv\u011bt\u0161\u00ed studie o l\u00e9\u010db\u011b rakoviny u lid\u00ed s kombinac\u00ed ivermektinu a mebendazolu byla nyn\u00ed recenzov\u00e1na a publikov\u00e1na v renomovan\u00e9m onkologick\u00e9m \u010dasopise.\" width=\"706\" height=\"704\" \/><\/figure>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">V tomto prospektivn\u00edm klinick\u00e9m hodnocen\u00ed z re\u00e1ln\u00e9ho sv\u011bta byla heterogenn\u00ed skupin\u011b pacient\u016f s rakovinou (\u00a0<\/span><strong><span dir=\"auto\">n=197<\/span><\/strong><span dir=\"auto\">\u00a0) p\u0159edeps\u00e1na\u00a0<\/span><strong><a href=\"https:\/\/www.twc.health\/products\/ivermectin-mebendazole?ref=APEX&amp;utm_medium=Affiliate%26utm_campaign\" target=\"_blank\" rel=\"noreferrer noopener\"><span dir=\"auto\">kombinace ivermektinu a mebendazolu<\/span><\/a><\/strong><span dir=\"auto\">\u00a0, p\u0159i\u010dem\u017e ka\u017ed\u00e1 kapsle obsahovala\u00a0<\/span><strong><span dir=\"auto\">25 mg ivermektinu a 250 mg mebendazolu<\/span><\/strong><span dir=\"auto\">\u00a0. \u00da\u010dastn\u00edci byli sledov\u00e1ni p\u0159ibli\u017en\u011b \u0161est m\u011bs\u00edc\u016f pomoc\u00ed standardizovan\u00fdch digit\u00e1ln\u00edch dotazn\u00edk\u016f k posouzen\u00ed v\u00fdsledk\u016f l\u00e9\u010dby rakoviny, dodr\u017eov\u00e1n\u00ed l\u00e9\u010dby a sn\u00e1\u0161enlivosti.<\/span><\/p>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">P\u0159ibli\u017en\u011b \u0161est m\u011bs\u00edc\u016f po zah\u00e1jen\u00ed l\u00e9\u010dby jsme pozorovali\u00a0<\/span><strong><span dir=\"auto\">m\u00edru klinick\u00e9ho p\u0159\u00ednosu (CBR) 84,4 %<\/span><\/strong><span dir=\"auto\">\u00a0\u2013 co\u017e znamen\u00e1, \u017ee v\u00edce ne\u017e \u010dty\u0159i z p\u011bti pacient\u016f hl\u00e1sili bu\u010f\u00a0<\/span><strong><span dir=\"auto\">\u017e\u00e1dn\u00e9 zn\u00e1mky onemocn\u011bn\u00ed (remise), regresi n\u00e1doru nebo stabilizaci rakoviny<\/span><\/strong><span dir=\"auto\">\u00a0.<\/span><\/p>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">T\u00e9m\u011b\u0159\u00a0<\/span><strong><span dir=\"auto\">polovina v\u0161ech pacient\u016f (48,4 %) hl\u00e1sila nejsiln\u011bj\u0161\u00ed pozitivn\u00ed v\u00fdsledky<\/span><\/strong><span dir=\"auto\">\u00a0, v\u010detn\u011b\u00a0<\/span><strong><span dir=\"auto\">absence zn\u00e1mek onemocn\u011bn\u00ed (32,8 %)<\/span><\/strong><span dir=\"auto\">\u00a0nebo\u00a0<\/span><strong><span dir=\"auto\">regrese n\u00e1doru (15,6 %)<\/span><\/strong><span dir=\"auto\">\u00a0. Dal\u0161\u00edch\u00a0<\/span><strong><span dir=\"auto\">36,1 % hl\u00e1silo stabilizaci onemocn\u011bn\u00ed<\/span><\/strong><span dir=\"auto\">\u00a0, zat\u00edmco pouze\u00a0<\/span><strong><span dir=\"auto\">15,6 % hl\u00e1silo progresi<\/span><\/strong><span dir=\"auto\">\u00a0.<\/span><\/p>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">D\u016fle\u017eit\u00e9 je, \u017ee adherence k l\u00e9\u010db\u011b byla pozoruhodn\u011b vysok\u00e1:\u00a0<\/span><strong><span dir=\"auto\">86,9 % pacient\u016f u\u017e\u00edvalo p\u016fvodn\u00ed p\u0159edpis v pln\u00e9 v\u00fd\u0161i<\/span><\/strong><span dir=\"auto\">\u00a0a\u00a0<\/span><strong><span dir=\"auto\">66,4 % pokra\u010dovalo v l\u00e9\u010db\u011b i po \u0161esti m\u011bs\u00edc\u00edch<\/span><\/strong><span dir=\"auto\">\u00a0.<\/span><\/p>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">Ne\u017e\u00e1douc\u00ed \u00fa\u010dinky byly v\u011bt\u0161inou m\u00edrn\u00e9 a zvl\u00e1dnuteln\u00e9,\u00a0<\/span><strong><span dir=\"auto\">vyskytly se u 25,4 % pacient\u016f<\/span><\/strong><span dir=\"auto\">\u00a0(zejm\u00e9na gastrointestin\u00e1ln\u00ed pot\u00ed\u017ee), p\u0159i\u010dem\u017e\u00a0<\/span><strong><span dir=\"auto\">93,6 % pacient\u016f s ne\u017e\u00e1douc\u00edmi \u00fa\u010dinky pokra\u010dovalo v l\u00e9\u010db\u011b i po drobn\u00fdch \u00faprav\u00e1ch d\u00e1vky.<\/span><\/strong><\/p>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">Tyto v\u00fdsledky jsou obzvl\u00e1\u0161t\u011b pozoruhodn\u00e9 t\u00edm, \u017ee se t\u00fdkaly\u00a0<\/span><strong><span dir=\"auto\">heterogenn\u00ed, realistick\u00e9 populace pacient\u016f s rakovinou<\/span><\/strong><span dir=\"auto\">\u00a0\u2013 v\u010detn\u011b pacient\u016f s n\u00e1dory prostaty, prsu, plic, st\u0159ev, jater a mnoha dal\u0161\u00edmi malign\u00edmi n\u00e1dory, z nich\u017e mnoz\u00ed tak\u00e9 podstupovali konven\u010dn\u00ed terapie, jako je chemoterapie, oza\u0159ov\u00e1n\u00ed a chirurgick\u00fd z\u00e1krok.<\/span><\/p>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">Tato pr\u016flomov\u00e1, recenzovan\u00e1 publikace vznikla d\u00edky unik\u00e1tn\u00ed spolupr\u00e1ci mezi\u00a0<\/span><strong><span dir=\"auto\">spole\u010dnost\u00ed The Wellness Company,<\/span><\/strong><span dir=\"auto\">\u00a0McCullough\u00a0<\/span><strong><span dir=\"auto\">Foundation<\/span><\/strong><span dir=\"auto\">\u00a0a\u00a0<\/span><strong><span dir=\"auto\">p\u0159edsedou prezidentsk\u00e9ho panelu pro rakovinu<\/span><\/strong><span dir=\"auto\">\u00a0\u2013 spojila klinick\u00e1 data z re\u00e1ln\u00e9ho sv\u011bta, zku\u0161enosti z prvn\u00ed linie l\u00e9ka\u0159\u016f a epidemiologick\u00e9 znalosti s c\u00edlem vyhodnotit n\u00e1kladov\u011b efektivn\u00ed, opakovan\u011b pou\u017eiteln\u00e9 terapie s velk\u00fdm transla\u010dn\u00edm potenci\u00e1lem.<\/span><\/p>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">Pr\u00e1ci provedli\u00a0<\/span><strong><span dir=\"auto\">Nicolas Hulscher, MPH (j\u00e1); Kelly Victory, MD; James A. Thorp, MD; Drew Pinsky, MD; Alejandro Diaz-Villalobos, MD; Peter Gillooly, MSc; Foster Coulson; Melissa Annazone; Chloe Radesi; Jessica Brooks; Peter A. McCullough, MD, MPH; a Harvey Risch, MD, PhD (p\u0159edseda prezidentsk\u00e9ho panelu pro rakovinu).<\/span><\/strong><\/p>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">Vzhledem k t\u011bmto mimo\u0159\u00e1dn\u011b slibn\u00fdm v\u00fdsledk\u016fm jsou nyn\u00ed nutn\u00e9 dvojit\u011b zaslepen\u00e9, placebem kontrolovan\u00e9 klinick\u00e9 studie. Mezit\u00edm mnoho pacient\u016f s rakovinou vyu\u017e\u00edv\u00e1 sv\u00e9ho pr\u00e1va to vyzkou\u0161et.<\/span><\/p>\n<p><strong><em><span dir=\"auto\">Od Nicolase Hulschera, MPH<\/span><\/em><\/strong><\/p>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">Cel\u00fd recenzovan\u00fd \u010dl\u00e1nek je k dispozici zde:\u00a0<\/span><strong><a href=\"https:\/\/ar.iiarjournals.org\/content\/46\/6\/3243\" target=\"_blank\" rel=\"noreferrer noopener\"><span dir=\"auto\">https:\/\/ar.iiarjournals.org\/content\/46\/6\/3243<\/span><\/a><\/strong><\/p>\n<p class=\"wp-block-paragraph\"><span dir=\"auto\">A na PubMed zde\u00a0<\/span><strong><span dir=\"auto\">:\u00a0<\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/42203321\/\" target=\"_blank\" rel=\"noreferrer noopener\"><span dir=\"auto\">https:\/\/pubmed.ncbi.nlm.nih.gov\/42203321\/<\/span><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n<div class=\"elementor-element elementor-element-8c57238 quelle dc-has-condition dc-condition-empty elementor-widget elementor-widget-heading\" data-id=\"8c57238\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n<div class=\"elementor-widget-container\">\n<h3 class=\"elementor-heading-title elementor-size-default\"><span style=\"font-size: 10pt;\"><a href=\"https:\/\/www.thefocalpoints.com\/p\/breaking-largest-human-cancer-study?utm_source=post-email-title&amp;publication_id=1119676&amp;post_id=199616174&amp;utm_campaign=email-post-title&amp;isFreemail=true&amp;r=3uby4s&amp;triedRedirect=true&amp;utm_medium=email\" target=\"_blank\" rel=\"nofollow noopener\"><span dir=\"auto\">Zdroj<\/span><\/a><\/span><\/h3>\n<p>&nbsp;<\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>84,4 % pacient\u016f s rakovinou, kte\u0159\u00ed u\u017e\u00edvali ivermektin + mebendazol po dobu 6 m\u011bs\u00edc\u016f, hl\u00e1silo&#8230;<\/p>\n","protected":false},"author":2,"featured_media":2321,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[518,1366,839],"_links":{"self":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/108028"}],"collection":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/comments?post=108028"}],"version-history":[{"count":0,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/108028\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media\/2321"}],"wp:attachment":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media?parent=108028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/categories?post=108028"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/tags?post=108028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}